Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Eytan Ben Ami"'
Autor:
Eyal Mor, Dan Assaf, Shanie Shemla, Eytan Ben-Ami, Danielle Mor-Hadar, Mirit Halfon, Shachar Laks, David Hazzan, Daria Perelson, Douglas Zippel, Almog Ben-Yaacov, Aviram Nissan, Mohammad Adileh
Publikováno v:
Journal of Surgical Research. 283:914-922
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dc72cfde2aa042e7f38e7c90aa4e3f0
https://doi.org/10.1016/j.jss.2022.10.026
https://doi.org/10.1016/j.jss.2022.10.026
Autor:
Ignacio Melero, Emiliano Calvo, Patricia LoRusso, Ravit Geva, Elena Garralda, Eytan Ben-Ami, Corinne Maurice-Dror, Michelle Niewood, Ulf Forssmann
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/379bcee62b0340ec8b973274c22a6c22
Autor:
Kyriakos P. Papadopoulos, Eytan Ben-Ami, Amita Patnaik, Denise Trone, Jianke Li, George D. Demetri
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Quizartinib, an inhibitor of class III receptor tyrosine kinases (RTKs), is currently in phase 3 development for the treatment of acute myeloid leukemia (AML) bearing internal tandem duplications in the FLT3 gene. Aberrant RTK sig
Externí odkaz:
https://doaj.org/article/8f9250fac8794f17a376923c809a046a
Autor:
Ignacio Melero, Maria Jure-Kunkel, Uğur Şahin, Tahamtan Ahmadi, Ulf Forssmann, Özlem Türeci, Kate Sasser, Eleni Lagkadinou, Gaurav Bajaj, Esther C.W. Breij, Sebastian Kreiter, David Satijn, Mustafa Diken, Mark Fereshteh, Edward N. van den Brink, Aras Toker, Theo S. Plantinga, Juliane Quinkhardt, Angelica Sette, Fulvia Vascotto, Dennis Verzijl, Eliana Stanganello, Saskia M. Burm, Theodora W. Salcedo, Bianca Sänger, Jordan M. Blum, Kristina B. Schoedel, Maria E. Rodriguez-Ruiz, Guzman Alonso, Patricia M. LoRusso, Emiliano Calvo, Corinne Maurice-Dror, Eytan Ben-Ami, Ravit Geva, Friederike Gieseke, Isil Altintas, Elena Garralda, Alexander Muik
Checkpoint inhibitors (CPI) have revolutionized the treatment paradigm for advanced solid tumors; however, there remains an opportunity to improve response rates and outcomes. In preclinical models, 4-1BB costimulation synergizes with CPIs targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77571654a67b8230111048825587e8ec
https://doi.org/10.1158/2159-8290.c.6549569
https://doi.org/10.1158/2159-8290.c.6549569
Autor:
Ignacio Melero, Maria Jure-Kunkel, Uğur Şahin, Tahamtan Ahmadi, Ulf Forssmann, Özlem Türeci, Kate Sasser, Eleni Lagkadinou, Gaurav Bajaj, Esther C.W. Breij, Sebastian Kreiter, David Satijn, Mustafa Diken, Mark Fereshteh, Edward N. van den Brink, Aras Toker, Theo S. Plantinga, Juliane Quinkhardt, Angelica Sette, Fulvia Vascotto, Dennis Verzijl, Eliana Stanganello, Saskia M. Burm, Theodora W. Salcedo, Bianca Sänger, Jordan M. Blum, Kristina B. Schoedel, Maria E. Rodriguez-Ruiz, Guzman Alonso, Patricia M. LoRusso, Emiliano Calvo, Corinne Maurice-Dror, Eytan Ben-Ami, Ravit Geva, Friederike Gieseke, Isil Altintas, Elena Garralda, Alexander Muik
Supplementary Figure from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e568b16421048c1e79b8dfceca7e687
https://doi.org/10.1158/2159-8290.22541198.v1
https://doi.org/10.1158/2159-8290.22541198.v1
Autor:
Jacob Schachter, Arnon Nagler, Avichai Shimoni, Eytan Ben-Ami, Alon Ben-Nun, Sara Apter, Ronit Yerushalmi, Gal Markel, Bruria Shalmon, Daniel Ohayon, Yaara Ohayon, Dragoslav Zikich, Noa Shoshani, Adva Kubi, Daphna Levy, Douglas B. Zippel, Avraham J. Treves, Orit Itzhaki, Ronnie Shapira-Frommer, Michal J. Besser
PDF file - 60K, the baseline characteristics and response to ipilimumab in 19 patients previously treated with TIL ACT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::619e5e4c5f7c46dc2fec1a71e0fcd835
https://doi.org/10.1158/1078-0432.22446417.v1
https://doi.org/10.1158/1078-0432.22446417.v1
Autor:
Jacob Schachter, Arnon Nagler, Avichai Shimoni, Eytan Ben-Ami, Alon Ben-Nun, Sara Apter, Ronit Yerushalmi, Gal Markel, Bruria Shalmon, Daniel Ohayon, Yaara Ohayon, Dragoslav Zikich, Noa Shoshani, Adva Kubi, Daphna Levy, Douglas B. Zippel, Avraham J. Treves, Orit Itzhaki, Ronnie Shapira-Frommer, Michal J. Besser
PDF file - 74K, the baseline and treatment characteristics of evaluated TIL patients treated with or without ipilimumab before TIL ACT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c20ef41de48768bfe42396034a20cf
https://doi.org/10.1158/1078-0432.22446420
https://doi.org/10.1158/1078-0432.22446420
Autor:
Jacob Schachter, Arnon Nagler, Avichai Shimoni, Eytan Ben-Ami, Alon Ben-Nun, Sara Apter, Ronit Yerushalmi, Gal Markel, Bruria Shalmon, Daniel Ohayon, Yaara Ohayon, Dragoslav Zikich, Noa Shoshani, Adva Kubi, Daphna Levy, Douglas B. Zippel, Avraham J. Treves, Orit Itzhaki, Ronnie Shapira-Frommer, Michal J. Besser
CCR Translation for This Article from Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d7e3214005d73a92538fe2f755c1de
https://doi.org/10.1158/1078-0432.22446429.v1
https://doi.org/10.1158/1078-0432.22446429.v1
Autor:
Jacob Schachter, Arnon Nagler, Avichai Shimoni, Eytan Ben-Ami, Alon Ben-Nun, Sara Apter, Ronit Yerushalmi, Gal Markel, Bruria Shalmon, Daniel Ohayon, Yaara Ohayon, Dragoslav Zikich, Noa Shoshani, Adva Kubi, Daphna Levy, Douglas B. Zippel, Avraham J. Treves, Orit Itzhaki, Ronnie Shapira-Frommer, Michal J. Besser
PDF file - 112K, the correlation of different variables to one another and their p values.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::929b81f4f7baa4c4300cb01d4a87ccc5
https://doi.org/10.1158/1078-0432.22446426.v1
https://doi.org/10.1158/1078-0432.22446426.v1
Autor:
Jacob Schachter, Arnon Nagler, Avichai Shimoni, Eytan Ben-Ami, Alon Ben-Nun, Sara Apter, Ronit Yerushalmi, Gal Markel, Bruria Shalmon, Daniel Ohayon, Yaara Ohayon, Dragoslav Zikich, Noa Shoshani, Adva Kubi, Daphna Levy, Douglas B. Zippel, Avraham J. Treves, Orit Itzhaki, Ronnie Shapira-Frommer, Michal J. Besser
PDF file - 43K, the objective responses of individual patients to various types of immunotherapies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a092bf255d3ef742542c8952ff49c99
https://doi.org/10.1158/1078-0432.22446423
https://doi.org/10.1158/1078-0432.22446423